3,4,5-tri- O -caffeoylquinic acid 3,4,5-tri- O -caffeoylquinic acid, a caffeoylquinic acid derivative, ameliorates the learning and memory deficits in ageing mouse models[192]
Over the past year, multiple pharmacovigilance bodies (WHO, EMA) have highlighted rare but clinically meaningful opticnerve events associated with GLP1 receptor agonists
While the scale may fluctuate and physical changes can take time, internal improvements may show up earlier in biomarkers related to glucose control, insulin function, inflammation, liver health, and cardiovascular risk
PCCA members with Clinical Services support can see 35 general suppository formulas that use a variety of compounding bases in our formula database
In one study, people who combined a GLP-1 medication with a supervised exercise program regained significantly less weight after stopping compared to those using medication alone